Clinical trial
Detection of AD Biomarkers in Tear Fluid
NCT04620902 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detection of AD Biomarkers in Tear Fluid
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- January 1, 2020
- Enrollment
- 69 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive impairment